A Study of NH280105 in Healthy Adult Participants

Summary

This is a Phase 1, randomized, double-blinded, placebo-controlled, single ascending dose (SAD) and multiple ascending dose (MAD) study to assess the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of NH280105 in healthy volunteers. In addition, this study will evaluate the effects of food on NH280105 under a two-period study setting.

Timeline

Start

2025-03-12

Primary completion

2025-11-13

Completion

2025-11-13

Drugs

Indications